
Sign up to save your podcasts
Or


Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
268268 ratings
Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

135 Listeners

318 Listeners

696 Listeners

493 Listeners

258 Listeners

262 Listeners

3,334 Listeners

1,152 Listeners

195 Listeners

86 Listeners

510 Listeners

364 Listeners

12 Listeners

248 Listeners

18 Listeners

15 Listeners

9 Listeners

430 Listeners

369 Listeners

45 Listeners

14 Listeners